首页> 外文期刊>Chest >Noninvasive Positive Airway Pressure and Risk of Myocardial Infarction in Acute Cardiogenic Pulmonary Edema: Continuous Positive Airway Pressure vs Noninvasive Positive Pressure Ventilation
【24h】

Noninvasive Positive Airway Pressure and Risk of Myocardial Infarction in Acute Cardiogenic Pulmonary Edema: Continuous Positive Airway Pressure vs Noninvasive Positive Pressure Ventilation

机译:急性心源性肺水肿的非侵入性气道正压和心肌梗死的风险:持续气道正压与无创正压通气

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The addition of both noninvasive continuous positive airway pressure (n-CPAP) ornnoninvasive intermittent positive pressure ventilation (n-IPPV) to medical treatment has been shownnto improve the outcome of patients with acute cardiogenic pulmonary edema (ACPE). Previousnstudies indicated a potential risk of new-onset acute myocardial infarction (AMI) associated with thenuse of n-IPPV. Although further studies did not confirm this observation, a few recent metaanalysesncould not eliminate all the doubts at this regards because of the paucity of data available and thenpresence of confounding factors. This study aims to assess whether the application of n-IPPV, asnopposed to n-CPAP, increases the rate of AMI in ACPE patients.nMethods: Fifty-two patients with severe hypoxemia consequent to ACPE were randomized to receivenn-CPAP (n u0001 27) or n-IPPV (n u0001 25) in addition to medical therapy. Patients with signs of acutencoronary syndrome on hospital admission were excluded from the study. Cardiac markers, ECG, andnclinical/physiologic parameters were assessed at study entry, after 30 and 60 min, and every6hfornthe first 2 days.nResults: No significant difference was observed in the rate of AMI (26.9% and 16% with n-CPAP andnn-IPPV, respectively, p u0001 0.244). Rate of intubation (p u0001 0.481), death (p u0001 0.662), and hospital stayn(p u0001 0.529) were not different between the two groups. Both techniques were effective in improvingngas exchange and vital signs in patients with ACPE.nConclusions: The AMI rate was not different with n-CPAP and n-IPPV, which resulted to be equallyneffective in the treatment of ACPE.nTrial registration: Clinicaltrials.gov Identifier: NCT00453947. (CHEST 2007; 132:1804–1809)
机译:背景:已证明在医学治疗中同时添加无创连续气道正压通气(n-CPAP)或无创间歇正压通气(n-IPPV)可以改善急性心源性肺水肿(ACPE)患者的预后。先前的研究表明,与随后使用n-IPPV相关的新发急性心肌梗塞(AMI)的潜在风险。尽管进一步的研究未能证实这一观察结果,但由于缺乏可用的数据以及混杂因素的存在,最近的一些荟萃分析无法消除所有关于这方面的疑问。这项研究旨在评估未加n-CPAP的n-IPPV是否会增加ACPE患者的AMI发生率.n方法:将52例因ACPE导致的严重低氧血症患者随机接受nn-CPAP(n u0001 27 )或n-IPPV(n u0001 25)以及药物治疗。入院时有急性冠状动脉综合症迹象的患者被排除在研究之外。在研究开始时,第30天和第60天以及第2天每6小时评估心脏标志物,心电图和临床/生理参数。n结果:AMI发生率无显着差异(n-CPAP和n分别为26.9%和16% -IPPV,分别为p u0001 0.244)。两组的插管率(p u0001 0.481),死亡率(p u0001 0.662)和住院时间(p u0001 0.529)均无差异。两种技术均能有效改善ACPE患者的气体交换和生命体征。n结论:n-CPAP和n-IPPV对AMI率无差异,因此在ACPE的治疗中同样有效。n试验注册:Clinicaltrials.gov标识符:NCT00453947。 (CHEST 2007; 132:1804-1809)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号